SCHEMBL7541774

SCHEMBL7541774

CCCCCCCCCCCCC(O)CNCCCCCCCCCCCC(CCCN)(CCCN)NCC(O)CCCCCCCCCCCC

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.40
ERAP2 Q6P179 1/20 0.40
GNAI3 P08754 2/20 0.38
GNAO1 P09471 2/20 0.38
GNAI1 P63096 2/20 0.38
SIRT6 Q8N6T7 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
SPHK1 Q9NYA1 1/20 0.34
RRM1 P23921 1/20 0.34
RELA Q04206 4/20 0.33
GPR84 Q9NQS5 4/20 0.33
DPP7 Q9UHL4 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
FFAR1 O14842 1/20 0.32
DNM1 Q05193 2/20 0.31
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7093917 0.90 DNM1 (0.39) GNAI3GNAO1GNAI1SIRT6SIRT1
SCHEMBL7098358 0.90 DNM1 (0.39) GNAI3GNAO1GNAI1SIRT6SIRT1
SCHEMBL9705885 0.84 GNAI3 (0.50) ANPEPERAP2GNAI3GNAO1GNAI1
SCHEMBL6825299 0.83 GNAI3 (0.49) ANPEPERAP2GNAI3GNAO1GNAI1
SCHEMBL10382687 0.83 SPHK1 (0.44) ANPEPERAP2GNAI3GNAO1GNAI1
SCHEMBL7095309 0.82 GNAI3 (0.48) ANPEPERAP2GNAI3GNAO1GNAI1
SCHEMBL7093133 0.82 GNAI3 (0.48) ANPEPERAP2GNAI3GNAO1GNAI1
SCHEMBL7497784 0.82 GNAI3 (0.48) ANPEPERAP2GNAI3GNAO1GNAI1
SCHEMBL7092727 0.82 RELA (0.48) ANPEPERAP2GNAI3GNAO1GNAI1
SCHEMBL27591629 0.82 RELA (0.48) ANPEPERAP2GNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242609-A2 NOVEL COLLOID SYNTHETIC VECTORS FOR GENE THERAPY Novartis AG (CH) 2002-09-25 EP disclosed
WO-2001049324-A2 NOVEL COLLOID SYNTHETIC VECTORS FOR GENE THERAPY NOVARTIS AG (CH) 2001-07-12 WO disclosed